{
    "info": {
        "nct_id": "NCT03976843",
        "official_title": "A Phase II Multi-Institutional Trial to Evaluate Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer",
        "inclusion_criteria": "* INCLUSION CRITERIA:\n* Patients must have histologically proven prostate adenocarcinoma confirmed by a CLIA certified laboratory.\n* Must have prostate cancer with high risk features defined as:\n\n  * Gleason 8 and higher OR\n  * PSA > 20 ng/mL OR\n  * Clinical stage T3a (i.e. likely extraprostatic extension on MRI) or T3b\n* Patients must be eligible for and must be planning to undergo radical prostatectomy and lymphadenectomy regardless of findings on 18F-DCFPyL PET/CT\n* Men age greater than or equal to 18 years.\n* ECOG performance status <2\n* Patients must have adequate organ and marrow function as defined below:\n\n  * Hemoglobin greater than or equal to 9 g/dL\n  * leukocytes greater than or equal to 3,000/mcL\n  * platelets greater than or equal to 100,000/mcL\n  * total bilirubin <2 X normal institutional limits\n* AST(SGOT)/ALT(SGPT) less than or equal to 3 X normal institutional limits\n* creatinine <2 X normal institutional limits\n\nOR\n\neGFR greater than or equal to 50 mL/min/1.73 m2 for patients with creatinine levels above institutional normal.\n\n* Ability of subject to understand and the willingness to sign a written informed consent document.\n* Willingness and ability to undergo biopsy of radiotracer-avid lesion if feasible.\n* Willingness and ability to undergo multiparametric prostate MRI and 18F-DCFPyL PET/CT\n\nEXCLUSION CRITERIA:\n\n* Any investigational agents in the past 28 days prior to enrollment.\n* Clinical stage T4 (tumor invades adjacent structures except seminal vesicles).\n* Distant metastatic disease on conventional imaging studies (computed tomography (CT)) of the abdomen and pelvis and bone scan. NaF PET/CT scan cannot substitute for a bone scan. Given lack of specificity of CT for lymph node metastases at lower thresholds, pelvic lymph nodes below 2 cm in the short axis are allowed.\n* Any prior hormone therapy used to treat prostate cancer, except limited androgen receptor antagonist therapy, defined as less than or equal to 3 days of treatment. The medication must be discontinued within 5 half-lives of the compound prior to study entry.\n* Any prior therapy for prostate cancer with surgery, radiation, and/or chemotherapy.\n* Contraindication to MRI or PET:\n\n  * Patients weighing more than weight limit for the scanner tables or unable to fit within the imaging gantry\n  * Prior reaction to 18F-DCFPyL\n  * Patients with pacemakers, cerebral aneurysm clips, shrapnel injury or implantable electronic device that are not MRI compatible at 3 T\n  * Severe claustrophobia unresponsive to oral anxiolytics\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Other medical conditions deemed by the principal investigator (or associates) to make the subject unsafe/ineligible for the protocol procedures or for radical prostatectomy.\n* A malignancy within the past 3 years for which prostatectomy is a contraindication.\n* Radiotracer administered within 5 half-lives prior to the date of 18F-DCFPyL PET/CT imaging.\n* PSMA-targeted imaging within 6 months with 18F-DCFPyL tracer prior to the date of 18F-DCFPyL PET/CT imaging. Participants can have PSMA targeted imaging with Gallium.\n* Unable to refrain from fathering a child or donating sperm for 10 days after each 18FDCFPyL injection.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Hemoglobin greater than or equal to 9 g/dL",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin greater than or equal to 9 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* creatinine <2 X normal institutional limits",
            "criterions": [
                {
                    "exact_snippets": "creatinine <2 X normal institutional limits",
                    "criterion": "creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 2,
                                "unit": "times normal institutional limits"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status <2",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status <2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must have histologically proven prostate adenocarcinoma confirmed by a CLIA certified laboratory.",
            "criterions": [
                {
                    "exact_snippets": "histologically proven prostate adenocarcinoma",
                    "criterion": "prostate adenocarcinoma",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "confirmed by a CLIA certified laboratory",
                    "criterion": "prostate adenocarcinoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation laboratory certification",
                            "expected_value": "CLIA certified"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Gleason 8 and higher OR",
            "criterions": [
                {
                    "exact_snippets": "Gleason 8 and higher",
                    "criterion": "Gleason score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Unable to refrain from fathering a child or donating sperm for 10 days after each 18FDCFPyL injection.",
            "criterions": [
                {
                    "exact_snippets": "Unable to refrain from fathering a child ... for 10 days after each 18FDCFPyL injection.",
                    "criterion": "fathering a child",
                    "requirements": [
                        {
                            "requirement_type": "refrain period",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Unable to refrain from ... donating sperm for 10 days after each 18FDCFPyL injection.",
                    "criterion": "donating sperm",
                    "requirements": [
                        {
                            "requirement_type": "refrain period",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinical stage T4 (tumor invades adjacent structures except seminal vesicles).",
            "criterions": [
                {
                    "exact_snippets": "Clinical stage T4",
                    "criterion": "clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "T4"
                        }
                    ]
                },
                {
                    "exact_snippets": "tumor invades adjacent structures except seminal vesicles",
                    "criterion": "tumor invasion of adjacent structures",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "exclusion",
                            "expected_value": "seminal vesicles"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must have adequate organ and marrow function as defined below:",
            "criterions": [
                {
                    "exact_snippets": "adequate organ and marrow function",
                    "criterion": "organ and marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Severe claustrophobia unresponsive to oral anxiolytics",
            "criterions": [
                {
                    "exact_snippets": "Severe claustrophobia unresponsive to oral anxiolytics",
                    "criterion": "claustrophobia",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        },
                        {
                            "requirement_type": "responsiveness to oral anxiolytics",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior reaction to 18F-DCFPyL",
            "criterions": [
                {
                    "exact_snippets": "Prior reaction to 18F-DCFPyL",
                    "criterion": "reaction to 18F-DCFPyL",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* PSMA-targeted imaging within 6 months with 18F-DCFPyL tracer prior to the date of 18F-DCFPyL PET/CT imaging. Participants can have PSMA targeted imaging with Gallium.",
            "criterions": [
                {
                    "exact_snippets": "PSMA-targeted imaging within 6 months with 18F-DCFPyL tracer prior to the date of 18F-DCFPyL PET/CT imaging",
                    "criterion": "PSMA-targeted imaging with 18F-DCFPyL tracer",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to the date of 18F-DCFPyL PET/CT imaging"
                        }
                    ]
                },
                {
                    "exact_snippets": "Participants can have PSMA targeted imaging with Gallium",
                    "criterion": "PSMA-targeted imaging with Gallium tracer",
                    "requirements": [
                        {
                            "requirement_type": "possibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinical stage T3a (i.e. likely extraprostatic extension on MRI) or T3b",
            "criterions": [
                {
                    "exact_snippets": "Clinical stage T3a",
                    "criterion": "clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "T3a"
                        }
                    ]
                },
                {
                    "exact_snippets": "T3a (i.e. likely extraprostatic extension on MRI)",
                    "criterion": "extraprostatic extension on MRI",
                    "requirements": [
                        {
                            "requirement_type": "likelihood",
                            "expected_value": "likely"
                        }
                    ]
                },
                {
                    "exact_snippets": "T3b",
                    "criterion": "clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "T3b"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with pacemakers, cerebral aneurysm clips, shrapnel injury or implantable electronic device that are not MRI compatible at 3 T",
            "criterions": [
                {
                    "exact_snippets": "Patients with pacemakers ... that are not MRI compatible at 3 T",
                    "criterion": "pacemaker",
                    "requirements": [
                        {
                            "requirement_type": "MRI compatibility at 3 T",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients with ... cerebral aneurysm clips ... that are not MRI compatible at 3 T",
                    "criterion": "cerebral aneurysm clips",
                    "requirements": [
                        {
                            "requirement_type": "MRI compatibility at 3 T",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients with ... shrapnel injury ... that are not MRI compatible at 3 T",
                    "criterion": "shrapnel injury",
                    "requirements": [
                        {
                            "requirement_type": "MRI compatibility at 3 T",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients with ... implantable electronic device that are not MRI compatible at 3 T",
                    "criterion": "implantable electronic device",
                    "requirements": [
                        {
                            "requirement_type": "MRI compatibility at 3 T",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any prior hormone therapy used to treat prostate cancer, except limited androgen receptor antagonist therapy, defined as less than or equal to 3 days of treatment. The medication must be discontinued within 5 half-lives of the compound prior to study entry.",
            "criterions": [
                {
                    "exact_snippets": "Any prior hormone therapy used to treat prostate cancer",
                    "criterion": "prior hormone therapy for prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "history of use",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "except limited androgen receptor antagonist therapy, defined as less than or equal to 3 days of treatment",
                    "criterion": "androgen receptor antagonist therapy duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "The medication must be discontinued within 5 half-lives of the compound prior to study entry.",
                    "criterion": "discontinuation of prior hormone therapy",
                    "requirements": [
                        {
                            "requirement_type": "discontinuation timing",
                            "expected_value": "within 5 half-lives of the compound prior to study entry"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Distant metastatic disease on conventional imaging studies (computed tomography (CT)) of the abdomen and pelvis and bone scan. NaF PET/CT scan cannot substitute for a bone scan. Given lack of specificity of CT for lymph node metastases at lower thresholds, pelvic lymph nodes below 2 cm in the short axis are allowed.",
            "criterions": [
                {
                    "exact_snippets": "Distant metastatic disease on conventional imaging studies (computed tomography (CT)) of the abdomen and pelvis and bone scan.",
                    "criterion": "distant metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "CT of the abdomen and pelvis",
                                "bone scan"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "NaF PET/CT scan cannot substitute for a bone scan.",
                    "criterion": "bone scan",
                    "requirements": [
                        {
                            "requirement_type": "detection_method",
                            "expected_value": "bone scan"
                        },
                        {
                            "requirement_type": "substitution_allowed",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "pelvic lymph nodes below 2 cm in the short axis are allowed.",
                    "criterion": "pelvic lymph node size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": "<",
                                "value": 2,
                                "unit": "cm"
                            }
                        },
                        {
                            "requirement_type": "location",
                            "expected_value": "pelvis"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* total bilirubin <2 X normal institutional limits",
            "criterions": [
                {
                    "exact_snippets": "total bilirubin <2 X normal institutional limits",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 2,
                                "unit": "times normal institutional limits"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Radiotracer administered within 5 half-lives prior to the date of 18F-DCFPyL PET/CT imaging.",
            "criterions": [
                {
                    "exact_snippets": "Radiotracer administered within 5 half-lives prior to the date of 18F-DCFPyL PET/CT imaging.",
                    "criterion": "radiotracer administration timing",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "half-lives prior to 18F-DCFPyL PET/CT imaging"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Other medical conditions deemed by the principal investigator (or associates) to make the subject unsafe/ineligible for the protocol procedures or for radical prostatectomy.",
            "criterions": [
                {
                    "exact_snippets": "Other medical conditions deemed by the principal investigator (or associates) to make the subject unsafe/ineligible for the protocol procedures or for radical prostatectomy.",
                    "criterion": "other medical conditions",
                    "requirements": [
                        {
                            "requirement_type": "safety for protocol procedures or radical prostatectomy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "eligibility for protocol procedures or radical prostatectomy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A malignancy within the past 3 years for which prostatectomy is a contraindication.",
            "criterions": [
                {
                    "exact_snippets": "A malignancy within the past 3 years",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "for which prostatectomy is a contraindication",
                    "criterion": "prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "contraindication",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability of subject to understand and the willingness to sign a written informed consent document.",
            "criterions": [
                {
                    "exact_snippets": "Ability of subject to understand",
                    "criterion": "subject's ability to understand",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent document",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "eGFR greater than or equal to 50 mL/min/1.73 m2 for patients with creatinine levels above institutional normal.",
            "criterions": [
                {
                    "exact_snippets": "eGFR greater than or equal to 50 mL/min/1.73 m2",
                    "criterion": "eGFR",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "mL/min/1.73 m2"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "for patients with creatinine levels above institutional normal",
                    "criterion": "creatinine level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": "> institutional normal"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* PSA > 20 ng/mL OR",
            "criterions": [
                {
                    "exact_snippets": "PSA > 20 ng/mL",
                    "criterion": "PSA",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 20,
                                "unit": "ng/mL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* platelets greater than or equal to 100,000/mcL",
            "criterions": [
                {
                    "exact_snippets": "platelets greater than or equal to 100,000/mcL",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "mcL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any investigational agents in the past 28 days prior to enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Any investigational agents in the past 28 days prior to enrollment.",
                    "criterion": "use of investigational agents",
                    "requirements": [
                        {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must have prostate cancer with high risk features defined as:",
            "criterions": [
                {
                    "exact_snippets": "Must have prostate cancer",
                    "criterion": "prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "high risk features defined as",
                    "criterion": "high risk features of prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willingness and ability to undergo multiparametric prostate MRI and 18F-DCFPyL PET/CT",
            "criterions": [
                {
                    "exact_snippets": "Willingness ... to undergo multiparametric prostate MRI",
                    "criterion": "multiparametric prostate MRI",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willingness ... to undergo ... 18F-DCFPyL PET/CT",
                    "criterion": "18F-DCFPyL PET/CT",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AST(SGOT)/ALT(SGPT) less than or equal to 3 X normal institutional limits",
            "criterions": [
                {
                    "exact_snippets": "AST(SGOT)/ALT(SGPT) less than or equal to 3 X normal institutional limits",
                    "criterion": "AST (SGOT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x upper limit of normal (ULN)"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "AST(SGOT)/ALT(SGPT) less than or equal to 3 X normal institutional limits",
                    "criterion": "ALT (SGPT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x upper limit of normal (ULN)"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any prior therapy for prostate cancer with surgery, radiation, and/or chemotherapy.",
            "criterions": [
                {
                    "exact_snippets": "Any prior therapy for prostate cancer with surgery, radiation, and/or chemotherapy.",
                    "criterion": "prior therapy for prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "treatment type",
                            "expected_value": [
                                "surgery",
                                "radiation",
                                "chemotherapy"
                            ]
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Men age greater than or equal to 18 years.",
            "criterions": [
                {
                    "exact_snippets": "Men age greater than or equal to 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "male"
                        },
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be MALE",
            "criterions": [
                {
                    "exact_snippets": "Must be MALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients weighing more than weight limit for the scanner tables or unable to fit within the imaging gantry",
            "criterions": [
                {
                    "exact_snippets": "Patients weighing more than weight limit for the scanner tables",
                    "criterion": "patient weight",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1000,
                                "unit": "scanner table weight limit"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unable to fit within the imaging gantry",
                    "criterion": "patient size/fit within imaging gantry",
                    "requirements": [
                        {
                            "requirement_type": "fit",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* leukocytes greater than or equal to 3,000/mcL",
            "criterions": [
                {
                    "exact_snippets": "leukocytes greater than or equal to 3,000/mcL",
                    "criterion": "leukocyte count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3000,
                                "unit": "mcL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "EXCLUSION CRITERIA:",
            "criterions": [
                {
                    "exact_snippets": "EXCLUSION CRITERIA:",
                    "criterion": "exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection",
                    "criterion": "ongoing or active infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... symptomatic congestive heart failure",
                    "criterion": "symptomatic congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... unstable angina pectoris",
                    "criterion": "unstable angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "psychiatric illness or social situations that would limit compliance with study requirements",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must be eligible for and must be planning to undergo radical prostatectomy and lymphadenectomy regardless of findings on 18F-DCFPyL PET/CT",
            "criterions": [
                {
                    "exact_snippets": "Patients must be eligible for ... radical prostatectomy",
                    "criterion": "radical prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must be planning to undergo radical prostatectomy",
                    "criterion": "radical prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "planned procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must be eligible for ... lymphadenectomy",
                    "criterion": "lymphadenectomy",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must be planning to undergo ... lymphadenectomy",
                    "criterion": "lymphadenectomy",
                    "requirements": [
                        {
                            "requirement_type": "planned procedure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willingness and ability to undergo biopsy of radiotracer-avid lesion if feasible.",
            "criterions": [
                {
                    "exact_snippets": "Willingness ... to undergo biopsy",
                    "criterion": "willingness to undergo biopsy",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "ability to undergo biopsy",
                    "criterion": "ability to undergo biopsy",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "biopsy of radiotracer-avid lesion",
                    "criterion": "radiotracer-avid lesion for biopsy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "if feasible",
                    "criterion": "biopsy feasibility",
                    "requirements": [
                        {
                            "requirement_type": "feasibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraindication to MRI or PET:",
            "criterions": [
                {
                    "exact_snippets": "Contraindication to MRI",
                    "criterion": "contraindication to MRI",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Contraindication to ... PET",
                    "criterion": "contraindication to PET",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "* INCLUSION CRITERIA:",
            "criterions": []
        },
        {
            "line": "OR",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}